Counseling our patients regarding cycle control
Andrew M. Kaunitz, MD
Professor and Associate Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville, Jacksonville, Florida
Catherine L. Dean, MD, MPH
Clinical Assistant Professor, Department of Obstetrics and Gynecology, Washington University School of Medicine, Managing Partner, Women’s HealthPartners, Inc., St. Louis, Missouri
Dr Kaunitz reports the following:
Consultant and/or speakers bureau, and research support: Bayer HealthCare Pharmaceuticals, Merck & Co., Inc., Ortho Women’s Health & Urology™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Teva Pharmaceuticals Industries Ltd. Dr Kaunitz has been compensated for his work on this publication.
Dr Dean reports the following:
Speakers bureau: Bayer HealthCare Pharmaceuticals, and Ortho Women’s Health & Urology™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. Dr Dean has been compensated for her work on this publication.
Highlights from a randomized clinical trial comparing a 21-day and a 24-day oral contraceptive regimen